Back to Journals » Drug Design, Development and Therapy » Volume 8

Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects

Total article views   Abstract views HTML views PDF downloads Totals
12,327 Dovepress* 10,929 945+ 1,123 11,874
PubMed Central* 0 453 127 453
Totals 10,929 1,398 1,250 12,327
*Since 26 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar